Back
BioVie Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
36
BIVI
BioVie
Last Price:
2.80
Seasonality Move:
18.19%
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
0.60
Seasonality Move:
1.46%
Sell
36
BioVie (BIVI)
is a Sell
Is BioVie a Buy, Sell or Hold?
- The current BioVie [BIVI] share price is $2.82. The Score for BIVI is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- BIVI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.61. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BIVI Stock Price Chart
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.
BIVI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 49.63 | Sell |
Chaikin Money Flow: | -350637 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.61 - 3.25) | Sell |
Bollinger Bands (100): | (1.87 - 3.79) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 39.49 | Sell |
Chaikin Money Flow: | -71560 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.63 - 0.75) | Sell |
Bollinger Bands (100): | (0.27 - 1.35) | Sell |
BIVI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.18 | Sell |
20-day SMA: | 2.98 | Sell |
50-day SMA: | 2.32 | Buy |
200-day SMA: | 4.52 | Sell |
8-day EMA: | 3.07 | Sell |
20-day EMA: | 2.94 | Sell |
50-day EMA: | 2.73 | Buy |
200-day EMA: | 7.52 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.68 | Sell |
20-day SMA: | 0.71 | Sell |
50-day SMA: | 0.67 | Sell |
200-day SMA: | 2.28 | Sell |
8-day EMA: | 0.67 | Sell |
20-day EMA: | 0.68 | Sell |
50-day EMA: | 0.72 | Sell |
200-day EMA: | 5.47 | Sell |
BioVie Earnings Growth & BIVI Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.80 per share, and an increase next year of $7.39 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
BioVie Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |